Health Care & Life Sciences » Biotechnology | Hualan Biological Engineering Inc.

Hualan Biological Engineering Inc. A | Income Statement

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,108
1,235
1,463
1,917
2,343
3,189
Cost of Goods Sold (COGS) incl. D&A
456
494
648
817
949
1,198
Gross Income
652
741
816
1,100
1,394
1,991
SG&A Expense
154
209
202
297
532
787
EBIT
461
509
575
846
830
1,189
Non Operating Income/Expense
49
56
4
2
16
86
Interest Expense
-
8
4
-
-
6
Pretax Income
561
631
701
914
915
1,369
Income Tax
85
89
111
133
120
180
Equity in Affiliates
-
3
8
10
9
21
Consolidated Net Income
476
539
582
771
804
1,210
Net Income
475
538
589
780
821
1,140
Net Income After Extraordinaries
475
538
589
780
821
1,140
Net Income Available to Common
475
538
589
780
821
1,140
EPS (Basic)
0.51
0.58
0.63
0.84
0.88
0.82
Basic Shares Outstanding
924
930
930
930
930
1,395
EPS (Diluted)
0.51
0.58
0.63
0.84
0.88
0.82
Diluted Shares Outstanding
924
930
930
930
930
1,395
EBITDA
565
623
695
992
978
1,329
Other Operating Expense
36
23
39
44
31
14
Non-Operating Interest Income
35
24
102
69
69
99
Minority Interest Expense
-
-
7
9
17
70

About Hualan Biological Engineering

View Profile
Address
No. 1 Hualan Avenue
Xinxiang Henan 453003
China
Employees -
Website http://www.hualanbio.com
Updated 07/08/2019
Hualan Biological Engineering, Inc. engages in the manufacture, production, commercialization, research and development of biopharmaceutical products. It focuses on human blood products, viral vaccines, bacterial vaccines and recombinant biologics. The company was founded on March 20, 1992 and is headquartered in Xinxiang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.